{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:24:06Z","timestamp":1787387046773,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12325-026-03668-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:00:11Z","timestamp":1782201611000},"page":"3756-3764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treating Severe Obesity: A Medical Perspective"],"prefix":"10.1007","volume":"43","author":[{"given":"Sujaytha","family":"Paknikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2464-3000","authenticated-orcid":false,"given":"Kalpana","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"3","key":"3668_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"3668_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.37619","volume":"8","author":"LT Fourman","year":"2025","unstructured":"Fourman LT, Awwad A, Guti\u00e9rrez-Sacrist\u00e1n A, et al. Implications of a new obesity definition among the all of us cohort. JAMA Netw Open. 2025;8(10):e2537619.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"3668_CR3","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1210\/clinem\/dgag097","volume":"111","author":"R Muniyappa","year":"2026","unstructured":"Muniyappa R, Chukir T, Desai D, et al. Defining disease or delaying care? A conceptual and clinical appraisal of the lancet obesity framework. J Clin Endocrinol Metab. 2026;111(6):1503\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"3668_CR4","unstructured":"Centers for Disease Control and Prevention. Adult BMI categories; 2024. https:\/\/www.cdc.gov\/bmi\/adult-calculator\/bmi-categories.html. Accessed on 6 Oct 2026."},{"issue":"2","key":"3668_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11695-021-05786-z","volume":"32","author":"K Verhoeff","year":"2022","unstructured":"Verhoeff K, Mocanu V, Dang J, et al. Five years of MBSAQIP data: characteristics, outcomes, and trends for patients with super-obesity. Obes Surg. 2022;32(2):406\u201315.","journal-title":"Obes Surg"},{"key":"3668_CR6","doi-asserted-by":"crossref","unstructured":"Corpodean F, Kachmar M, Yang S, et al. Association of obesity severity with cardiometabolic and renal disease burden in the United States. Obesity (Silver Spring). 2025.","DOI":"10.1002\/oby.70099"},{"issue":"7","key":"3668_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.puhe.2007.01.006","volume":"121","author":"R Sturm","year":"2007","unstructured":"Sturm R. Increases in morbid obesity in the USA: 2000\u20132005. Public Health. 2007;121(7):492\u20136.","journal-title":"Public Health"},{"issue":"6","key":"3668_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S2213-8587(25)00069-5","volume":"13","author":"M Kachmar","year":"2025","unstructured":"Kachmar M, Albaugh VL, Yang S, et al. Disproportionate increase in BMI of \u226560\u00a0kg\/m(2) in the USA. Lancet Diabetes Endocrinol. 2025;13(6):463\u20135.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10046","key":"3668_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"BMIMC Global","year":"2016","unstructured":"Global BMIMC, Di Angelantonio E, Bhupathiraju ShN, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776\u201386.","journal-title":"Lancet"},{"issue":"7","key":"3668_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1017\/S1368980009993193","volume":"13","author":"J O'Connell","year":"2010","unstructured":"O\u2019Connell J, Kieran P, Gorman K, Ahern T, Cawood TJ, O\u2019Shea D. BMI > or = 50\u00a0kg\/m2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profiles. Public Health Nutr. 2010;13(7):1090\u20138.","journal-title":"Public Health Nutr"},{"issue":"19","key":"3668_CR11","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.3390\/jcm12196396","volume":"12","author":"AW Al-Humadi","year":"2023","unstructured":"Al-Humadi AW, Alabduljabbar K, Alsaqaaby MS, Talaee H, le Roux CW. Obesity characteristics are poor predictors of genetic mutations associated with obesity. J Clin Med. 2023;12(19):6396.","journal-title":"J Clin Med"},{"issue":"10","key":"3668_CR12","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41366-018-0209-8","volume":"43","author":"P Stahel","year":"2019","unstructured":"Stahel P, Sud SK, Lee SJ, et al. Phenotypic and genetic analysis of an adult cohort with extreme obesity. Int J Obes (Lond). 2019;43(10):2057\u201365.","journal-title":"Int J Obes (Lond)"},{"issue":"15","key":"3668_CR13","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.3390\/nu17152573","volume":"17","author":"M Herstowska","year":"2025","unstructured":"Herstowska M, My\u015bliwiec K, Bandura M, et al. Beyond Metabolism: psychiatric and social dimensions in bariatric surgery candidates with a BMI \u2265 50-a prospective cohort study. Nutrients. 2025;17(15):2573.","journal-title":"Nutrients"},{"issue":"13\u201314","key":"3668_CR14","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/jocn.15679","volume":"30","author":"SL Huang","year":"2021","unstructured":"Huang SL, Cheng H, Duffield C, Denney-Wilson E. The relationship between patient obesity and nursing workload: an integrative review. J Clin Nurs. 2021;30(13\u201314):1810\u201325.","journal-title":"J Clin Nurs"},{"issue":"6","key":"3668_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S2213-8587(24)00098-6","volume":"12","author":"MS Alsaqaaby","year":"2024","unstructured":"Alsaqaaby MS, Cooney S, le Roux CW, Pournaras DJ. Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review. Lancet Diabetes Endocrinol. 2024;12(6):414\u201321.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3668_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0\u00a0mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"11","key":"3668_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"3","key":"3668_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"3668_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/oby.2011.330","volume":"20","author":"DB Allison","year":"2012","unstructured":"Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330\u201342.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"3668_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12734","volume":"15","author":"DB Horn","year":"2025","unstructured":"Horn DB, Kahan S, Batterham RL, et al. Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials. Clin Obes. 2025;15(3):e12734.","journal-title":"Clin Obes"},{"issue":"4","key":"3668_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/oby.23732","volume":"31","author":"BM McGowan","year":"2023","unstructured":"McGowan BM, Houshmand-Oeregaard A, Laursen PN, Zeuthen N, Baker-Knight J. Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: post hoc analyses of the STEP 1 randomized trial. Obesity (Silver Spring). 2023;31(4):990\u20139.","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"3668_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jamainternmed.2023.8526","volume":"184","author":"SZ Yanovski","year":"2024","unstructured":"Yanovski SZ, Yanovski JA. Approach to obesity treatment in primary care: a review. JAMA Intern Med. 2024;184(7):818\u201329.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"3668_CR23","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s11695-025-08137-4","volume":"35","author":"A Esparham","year":"2025","unstructured":"Esparham A, Sheikhbahaei E, Anari Moghadam H, Khorgami Z. Preoperative glucagon-like peptide-1 receptor agonists and bariatric surgery outcomes: a systematic review. Obes Surg. 2025;35(9):3939\u201346.","journal-title":"Obes Surg"},{"issue":"12","key":"3668_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","volume":"20","author":"TL Kindel","year":"2024","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Obes Relat Dis. 2024;20(12):1183\u20136.","journal-title":"Surg Obes Relat Dis"},{"issue":"14","key":"3668_CR25","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414\u201325.","journal-title":"JAMA"},{"issue":"7","key":"3668_CR26","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1007\/s00464-025-11838-7","volume":"39","author":"M Friesch","year":"2025","unstructured":"Friesch M, Fernando M, Sheedy E, et al. Effects of preoperative glucagon-like peptide-1 receptor agonist therapy on weight loss following bariatric surgery. Surg Endosc. 2025;39(7):4545\u201350.","journal-title":"Surg Endosc"},{"issue":"2","key":"3668_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11695-024-07651-1","volume":"35","author":"Q AbuHasan","year":"2025","unstructured":"AbuHasan Q, Funk LM, Holl JL, et al. Preoperative glucagon-like peptide-1 receptor agonist utilization and association with bariatric surgery outcomes. Obes Surg. 2025;35(2):556\u201360.","journal-title":"Obes Surg"},{"issue":"10","key":"3668_CR28","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1007\/s11695-025-08258-w","volume":"35","author":"G Luc","year":"2025","unstructured":"Luc G, Dedieu A, Canard G, et al. Exploratory assessment of preoperative GLP-1 receptor agonists before sleeve gastrectomy: a retrospective matched analysis. Obes Surg. 2025;35(10):4383\u201392.","journal-title":"Obes Surg"},{"issue":"5","key":"3668_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2025.0001","volume":"160","author":"V Mathur","year":"2025","unstructured":"Mathur V, Wasden K, Shin TH, et al. Neoadjuvant semaglutide, bariatric surgery weight loss, and overall outcomes. JAMA Surg. 2025;160(5):594\u20136.","journal-title":"JAMA Surg"},{"issue":"9","key":"3668_CR30","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s11695-025-08054-6","volume":"35","author":"M Faran","year":"2025","unstructured":"Faran M, O\u2019Callaghan EK, McKechnie T, et al. Evaluating weight loss associated with bariatric surgery after liraglutide use: a matched population-level retrospective cohort study. Obes Surg. 2025;35(9):3676\u201385.","journal-title":"Obes Surg"},{"issue":"9","key":"3668_CR31","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1007\/s00464-025-11851-w","volume":"39","author":"AD Obermark","year":"2025","unstructured":"Obermark AD, Seo DY, Bernazard A, et al. Bariatric outcomes of high BMI patients with preoperative anti-obesity medications. Surg Endosc. 2025;39(9):6061\u20138.","journal-title":"Surg Endosc"},{"issue":"11","key":"3668_CR32","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","volume":"29","author":"TA Wadden","year":"2023","unstructured":"Wadden TA, Chao AM, Machineni S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase\u00a03 trial. Nat Med. 2023;29(11):2909\u201318.","journal-title":"Nat Med"},{"issue":"12","key":"3668_CR33","doi-asserted-by":"publisher","first-page":"znae284","DOI":"10.1093\/bjs\/znae284","volume":"111","author":"RV Cohen","year":"2024","unstructured":"Cohen RV, Park JY, Prager G, et al. Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review. Br J Surg. 2024;111(12):znae284.","journal-title":"Br J Surg"},{"issue":"8","key":"3668_CR34","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s11695-021-05446-2","volume":"31","author":"R Li","year":"2021","unstructured":"Li R, Veltzke-Schlieker W, Adler A, et al. Endoscopic sleeve gastroplasty (ESG) for high-risk patients, high body mass index (> 50\u00a0kg\/m2) patients, and contraindication to abdominal surgery. Obes Surg. 2021;31(8):3400\u20139.","journal-title":"Obes Surg"},{"issue":"5","key":"3668_CR35","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s11695-025-07838-0","volume":"35","author":"M Kermansaravi","year":"2025","unstructured":"Kermansaravi M, Esparham A, Parmar C, et al. Intragastric balloon as a bridge before metabolic and bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025;35(5):1934\u201346.","journal-title":"Obes Surg"},{"issue":"11","key":"3668_CR36","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1007\/s00464-019-07027-y","volume":"33","author":"Y Lee","year":"2019","unstructured":"Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S. Bridging interventions before bariatric surgery in patients with BMI\u2009\u2265\u200950\u00a0kg\/m2: a systematic review and meta-analysis. Surg Endosc. 2019;33(11):3578\u201388.","journal-title":"Surg Endosc"},{"issue":"8","key":"3668_CR37","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s11695-025-07996-1","volume":"35","author":"Y Xu","year":"2025","unstructured":"Xu Y, Yang S, Luo R, et al. Optimizing bariatric surgery outcomes: the dual benefits of preoperative very-low-calorie diets. Obes Surg. 2025;35(8):3057\u201363.","journal-title":"Obes Surg"},{"issue":"9","key":"3668_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jama.2020.12567","volume":"324","author":"DE Arterburn","year":"2020","unstructured":"Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879\u201387.","journal-title":"JAMA"},{"issue":"11","key":"3668_CR39","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1007\/s11695-025-08212-w","volume":"35","author":"N Jumaev","year":"2025","unstructured":"Jumaev N, Teshaev O, Tavasharov B, Lekomseva M. Mortality after bariatric surgery: a comprehensive review. Obes Surg. 2025;35(11):4797\u2013805.","journal-title":"Obes Surg"},{"issue":"8","key":"3668_CR40","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00464-021-08329-w","volume":"35","author":"DI Athanasiadis","year":"2021","unstructured":"Athanasiadis DI, Martin A, Kapsampelis P, Monfared S, Stefanidis D. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc. 2021;35(8):4069\u201384.","journal-title":"Surg Endosc"},{"issue":"6","key":"3668_CR41","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1007\/s00464-022-09785-8","volume":"37","author":"EO Akpinar","year":"2023","unstructured":"Akpinar EO, Liem RSL, Nienhuijs SW, Greve JWM, de Marang-van Mheen PJ. Weight recurrence after sleeve gastrectomy versus Roux-en-Y gastric bypass: a propensity score matched nationwide analysis. Surg Endosc. 2023;37(6):4351\u20139.","journal-title":"Surg Endosc"},{"issue":"3","key":"3668_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11695-025-07733-8","volume":"35","author":"Y Nie","year":"2025","unstructured":"Nie Y, Zhang Y, Liu B, Meng H. Glucagon-like peptide-1 receptor agonists for the treatment of suboptimal initial clinical response and weight gain recurrence after bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025;35(3):808\u201322.","journal-title":"Obes Surg"},{"issue":"10","key":"3668_CR43","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1007\/s11695-025-08210-y","volume":"35","author":"H Abdallah","year":"2025","unstructured":"Abdallah H, Klink WH, Derienne J, et al. Interest in treatment with GLP-1 receptor agonists for the management of insufficient weight loss or weight regain after bariatric surgery. Obes Surg. 2025;35(10):4286\u201391.","journal-title":"Obes Surg"},{"issue":"9","key":"3668_CR44","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1007\/s00464-025-11942-8","volume":"39","author":"A Brown","year":"2025","unstructured":"Brown A, Sergent H, Vu AH, et al. Sleeve-to-bypass conversion vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study. Surg Endosc. 2025;39(9):6155\u201362.","journal-title":"Surg Endosc"},{"issue":"8","key":"3668_CR45","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1007\/s00464-025-11910-2","volume":"39","author":"K Wasden","year":"2025","unstructured":"Wasden K, Mathur V, Martin TJ, et al. Recurrent weight gain after sleeve gastrectomy: conversion to Roux-en-Y gastric bypass versus novel GLP-1 s. Surg Endosc. 2025;39(8):5303\u201314.","journal-title":"Surg Endosc"},{"issue":"4","key":"3668_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.gie.2025.05.020","volume":"102","author":"P Jirapinyo","year":"2025","unstructured":"Jirapinyo P, Kumar N, Thompson CC, et al. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy preservation and incorporation of valuable endoscopic innovations thresholds for transoral outlet reduction. Gastrointest Endosc. 2025;102(4):440-53.e6.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"3668_CR47","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11695-025-07671-5","volume":"35","author":"A Lahooti","year":"2025","unstructured":"Lahooti A, Hoff AC, Critelli B, et al. A randomized, double-blind, two-way cross-over study to evaluate the efficacy of liraglutide treatment in patients undergoing transoral outlet reduction endoscopy for weight regain post Roux-en-Y gastric bypass. Obes Surg. 2025;35(3):775\u201383.","journal-title":"Obes Surg"},{"issue":"3","key":"3668_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/cob.70001","volume":"15","author":"F Bahdi","year":"2025","unstructured":"Bahdi F, Shah S, Dahoud F, et al. Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy. Clin Obes. 2025;15(3):e70001.","journal-title":"Clin Obes"},{"issue":"5","key":"3668_CR49","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/dom.15473","volume":"26","author":"H Gasoyan","year":"2024","unstructured":"Gasoyan H, Pfoh ER, Schulte R, Sullivan E, Le P, Rothberg MB. Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills. Diabetes Obes Metab. 2024;26(5):1687\u201396.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3668_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13679-025-00639-7","volume":"14","author":"KM Ross","year":"2025","unstructured":"Ross KM, Worwag KE, Swanson TN, Shetty A, Barrett KL. Health disparities in obesity treatment outcomes, access, and utilization. Curr Obes Rep. 2025;14(1):47.","journal-title":"Curr Obes Rep"},{"issue":"9","key":"3668_CR51","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/oby.24331","volume":"33","author":"H Gasoyan","year":"2025","unstructured":"Gasoyan H, Butsch WS, Schulte R, et al. Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status. Obesity (Silver Spring). 2025;33(9):1657\u201367.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"3668_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"3668_CR53","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1111\/dom.16405","volume":"27","author":"M Naveed","year":"2025","unstructured":"Naveed M, Perez C, Ahmad E, Russell L, Lees Z, Maybury C. GLP-1 medication and weight loss: barriers and motivators among 1659 participants managed in a virtual setting. Diabetes Obes Metab. 2025;27(7):3780\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"3668_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2025.100621","volume":"9","author":"A Fitch","year":"2025","unstructured":"Fitch A. Setting expectations when prescribing medication for the treatment of patients with obesity. Mayo Clin Proc Innov Qual Outcomes. 2025;9(3):100621.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03668-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:04:28Z","timestamp":1787385868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03668-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3668"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03668-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sujaytha Paknikar and Kalpana Muthusamy have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}